AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Journey Medical Corporati... (DERM)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.10

0.12 (2.41%)

At close: Feb 20, 2025, 3:59 PM

5.14

0.78%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	4.71
Market Cap	106.54M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.92
PE Ratio (ttm)	-5.54
Forward PE	n/a
Analyst	Buy

Ask	5.3
Volume	78,274
Avg. Volume (20D)	75,462
Open	4.96
Previous Close	4.98
Day's Range	4.90 - 5.11
52-Week Range	2.85 - 6.89
Beta	undefined

About DERM

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; X...

[Show more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

IPO Date Nov 12, 2021

Employees 41

Stock Exchange NASDAQ

Ticker Symbol DERM

Website https://journeymedicalcorp.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for DERM stock is "Buy." The 12-month stock price forecast is $10, which is an increase of 96.08% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Journey Medical Corporation is scheduled to release its earnings on Mar 20, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

6 months ago

+14.22%

Journey Medical shares are trading higher after th... Unlock content with Pro Subscription

11 months ago

-13.61%

Journey Medical shares are trading lower. The company reported Q4 financial results.

News

2 weeks ago · seekingalpha.com

Stock Picks From Seeking Alpha's January 2025 New Analysts

In January, Seeking Alpha welcomed 29 new analysts. This article introduces them and showcases some of their top picks. Analysts highlighted include The Conservative Investor recommending Dassault Avi...

3 weeks ago · seekingalpha.com

Journey Medical Corporation: Emrosi's Launch Could Be A Turning Point

Journey Medical's future hinges on Emrosi™, a new formulation of minocycline for rosacea, showing superior efficacy over Oracea® in Phase III trials. Despite current financial challenges and a need fo...